What does this research mean for the field?

Whole-body MRI screening can identify early cancers in individuals with Li–Fraumeni syndrome. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the effectiveness of whole-body MRI (WB-MRI) for early cancer detection in patients with Li-Fraumeni syndrome (LFS).

February 28, 2026Open Access

SIGNIFIED: whole-body MRI screening in Li–Fraumeni syndrome in the UK

Key Points

To evaluate the effectiveness of whole-body MRI (WB-MRI) for early cancer detection in patients with Li-Fraumeni syndrome (LFS).
Conducted baseline and 12-month follow-up WB-MRI screenings in LFS patients
Monitored for early cancer detection and incidental findings
Assessed the impact of repeat imaging on further investigations
Early cancers were detected at both baseline and 12-month follow-up screenings
Incidental findings led to decreased burden of additional investigations with repeat imaging

Abstract

WB-MRI can identify early cancers in the high-risk setting of LFS screening, with cancers detected at both baseline and 12-month follow-up screenings. The burden of additional investigations for incidental findings decreases with repeat imaging.

SIGNIFIED: whole-body MRI screening in Li–Fraumeni syndrome in the UK

Key Points

Abstract

Cite This Study